Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,779) with videos related to
Page
of 178
Sort By:
Mabs
|
December 18, 2014
Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody
Noriyuki Kasai, Yukitaka Yoshikawa, Junichi Enokizono
Mabs
|
December 18, 2014
A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies
Jan Stracke, Thomas Emrich, Petra Rueger, et al.
Mabs
|
December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
Magdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Mabs
|
August 1, 2015
Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys
S Dudal, K Subramanian, T Flandre, et al.
Mabs
|
December 9, 2014
Raman spectroscopy characterization of antibody phases in serum
Audrey E Baker, Amber R Mantz, Mark L Chiu
Mabs
|
December 9, 2014
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
Chien-Hsing Chang, Yang Wang, Pankaj Gupta, et al.
Mabs
|
December 9, 2014
Characterizing monoclonal antibody structure by carbodiimide/GEE footprinting
Parminder Kaur, Sara Tomechko, Janna Kiselar, et al.
Mabs
|
December 9, 2014
Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors
Jérémy Loyau, Pauline Malinge, Bruno Daubeuf, et al.
Mabs
|
December 9, 2014
Russell body phenotype is preferentially induced by IgG mAb clones with high intrinsic condensation propensity: relations between the biosynthetic events in the ER and solution behaviors in vitro
Haruki Hasegawa, Christopher E Woods, Francis Kinderman, et al.
Mabs
|
December 9, 2014
Antibodies to watch in 2015
Janice M Reichert
Page
of 178
Search research articles
Search
Showing results (1161-1170 of 1,779) with videos related to
Sort By:
Page
of 178
Mabs
|
December 18, 2014
Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody
Noriyuki Kasai, Yukitaka Yoshikawa, Junichi Enokizono
Mabs
|
December 18, 2014
A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies
Jan Stracke, Thomas Emrich, Petra Rueger, et al.
Mabs
|
December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
Magdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Mabs
|
August 1, 2015
Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys
S Dudal, K Subramanian, T Flandre, et al.
Mabs
|
December 9, 2014
Raman spectroscopy characterization of antibody phases in serum
Audrey E Baker, Amber R Mantz, Mark L Chiu
Mabs
|
December 9, 2014
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
Chien-Hsing Chang, Yang Wang, Pankaj Gupta, et al.
Mabs
|
December 9, 2014
Characterizing monoclonal antibody structure by carbodiimide/GEE footprinting
Parminder Kaur, Sara Tomechko, Janna Kiselar, et al.
Mabs
|
December 9, 2014
Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors
Jérémy Loyau, Pauline Malinge, Bruno Daubeuf, et al.
Mabs
|
December 9, 2014
Russell body phenotype is preferentially induced by IgG mAb clones with high intrinsic condensation propensity: relations between the biosynthetic events in the ER and solution behaviors in vitro
Haruki Hasegawa, Christopher E Woods, Francis Kinderman, et al.
Mabs
|
December 9, 2014
Antibodies to watch in 2015
Janice M Reichert
Page
of 178